| AbCellera Announces Presentation on T-cell Engager Platform at the Society for Immunotherapy of Cancer (SITC) Annual Meeting 2024 | 10/04 09:00 | businesswire.com |
| AbCellera to Report Third Quarter 2024 Financial Results on November 4, 2024 | 09/26 16:05 | businesswire.com |
| AbCellera: A Waiting Game With High Uncertainty | 08/23 04:43 | seekingalpha.com |
| AbCellera Biologics Inc. (ABCL) Reports Q2 Loss, Misses Revenue Estimates | 08/06 19:15 | zacks.com |
| 5 Penny Stocks With 250% Upside in 1 Year According to Wall Street | 07/30 08:49 | 247wallst.com |
| Billionaires Are Buying These 2 Beaten-Down Stocks. Are They Smart Buys for Your Portfolio? | 07/21 05:37 | fool.com |
| AbCellera Biologics (ABCL) Upgraded to Buy: Here's What You Should Know | 07/09 13:01 | zacks.com |
| AbCellera to Report Second Quarter 2024 Financial Results on August 6, 2024 | 06/25 16:05 | businesswire.com |
| Down 57%, Is AbCellera Biologics a Buy on the Dip? | 06/13 05:40 | fool.com |
| AbCellera to Present at the Goldman Sachs 45th Annual Global Healthcare Conference on June 10, 2024 | 05/28 16:05 | businesswire.com |